Applied Biosystems, now part of Invitrogen, was the first to pioneer a sequencing-by-ligation process, marketing it under the name of SOLiD. The process has some interesting features and is the ...

Applied Biosystems has announced the worldwide commercial availability of SOLiD, the company’s next-generation DNA sequencing platform, which is expected to simplify the identification ...

There's always a new trendy diet plan. But how effective is meal sequencing, actually? Nutrition experts explain.

Applied Biosystems' SOLiD system 1 is a commonly used massively parallel DNA sequencing platform for applications from genotyping and structural variation analysis 1 to transcriptome ...

Their findings, published in the Proceedings of the National Academy of Sciences, pave the way for solid-state, label-free DNA sequencing technologies with implications for precision medicine.

Cancer cell monitoring startup Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with solid tumours. The company is based in ...

Scientists at the University of Michigan wanted to understand what makes solid tumors spread—and, by extension, how the growing selection of personalized drugs could best be employed in patients ...

Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors, according to the multi-center study.

In this case, the tethered PCR approach that we mentioned in covering SOLiD sequencing, in which beads wound up covered with multiple copies of an identical sequence, is also used by an otherwise ...

Our Lab established next-generation sequencing (NGS) in 2017 to detect molecular alterations in solid tumors for diagnosis and to identify therapeutic targets. Our Lab is referral for various regional ...

Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors, according to the multicenter Individualized ...